CLINICAL_TRIALS
trial_result
· 2017-09-15
Clinical Trial Update: Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors [Phase 3]
Summary
Phase 3 trial of tofacitinib in psoriatic arthritis patients with inadequate response to TNF inhibitors has completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-09-15